Wikidata

(Q45191184)

English

Treatment of pulmonary arterial hypertension (PAH) with oral endothelin-receptor antagonist bosentan in systemic sclerosis: BREATHE-1 trial and clinical experience

scientific article published in December 2004

In more languages

Statements

title
Treatment of pulmonary arterial hypertension (PAH) with oral endothelin-receptor antagonist bosentan in systemic sclerosis: BREATHE-1 trial and clinical experience (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15605216
retrieved
10 December 2017
author name string
K Ahmadi-Simab
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15605216
retrieved
10 December 2017
P Lamprecht
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15605216
retrieved
10 December 2017
B Hellmisch
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15605216
retrieved
10 December 2017
W L Gross
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15605216
retrieved
10 December 2017
publication date
1 December 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15605216
retrieved
10 December 2017
page(s)
495-497
1 reference
stated in
Europe PubMed Central
PubMed ID
15605216
retrieved
10 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q45191184&oldid=2069439859"